# Can fasting insulin explain a weight-loss plateau?

A fasting insulin result cannot decide whether a medication should change. Learn what glucose tests and a treatment review can clarify.

Canonical: https://velri.co/blog/tirzepatide-fasting-insulin-stalled-metabolic-switch
Publisher: Velri (https://velri.co/about)
Published: 2026-07-02
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A fasting insulin result alone cannot explain a weight-loss plateau or decide whether someone should switch medication. Insulin resistance is a real biological process, but testing for it is not as straightforward as finding one number above an internet target.

NIDDK notes that health professionals may not test directly for insulin resistance; the relevant testing is used mainly in research. Prediabetes is assessed using established glucose tests instead.[1]

## Insulin and glucose are different measurements

Insulin helps glucose enter cells. With insulin resistance, cells respond less effectively, and the pancreas may make more insulin to compensate.

A fasting insulin test measures insulin at one point in time. It does not directly measure how much body fat someone has, why their weight has stopped changing, or how well a particular medication will work.

A1c, fasting plasma glucose, and an oral glucose tolerance test answer different questions about blood glucose. None should be treated as interchangeable with a fasting insulin value.[1]

## What matters when weight stops changing

A medication review needs a timeline: the treatment used, how long it has been taken, changes in weight, side effects, and interruptions. Changes in eating, activity, sleep, and other medicines can also give context.

Maintaining a previous weight reduction is different from having no response at all. Looking only at the last weigh-in can hide that distinction.

Medication decisions also depend on health conditions, treatment goals, tolerability, and the benefits achieved. A lab result can inform that discussion without controlling it.[2]

## Be cautious with an “optimal insulin” target

A single target presented as the answer to stalled weight loss can create false certainty. Before paying for repeat testing, establish what the result would change.

If the concern is prediabetes, use the tests intended to evaluate glucose. If the concern is a plateau, review the whole treatment course. Those are related questions, but they are not the same question.

## Sources
[1] Insulin Resistance & Prediabetes - NIDDK. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
[2] Prescription Medications to Treat Overweight & Obesity - NIDDK. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support